Curative Biotechnology (CUBT) Stock Chart & Stock Price History $0.0093 +0.00 (+1.09%) As of 08/1/2025 01:51 PM Eastern Add Compare Share Share Chart Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Curative Biotechnology Stock Price Performance The Curative Biotechnology (CUBT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 44.97%, with a year-to-date return of -27.34%. In the past month, the stock has decreased 16.22%, reflecting recent market activity. As of the latest close, Curative Biotechnology traded at $0.01 with a market cap of $9.42 million and volume of 12,000 shares. Receive CUBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.06%1 Month Performance-16.22%3 Month Performance-23.77%Year-To-Date Performance-27.34%1 Year Performance-44.97% CUBT Stock Chart for Saturday, August, 2, 2025 CUBT Chart by TradingView Curative Biotechnology Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.01$0.01+1.09%$0.01$0.0112,000 shs$9.42 million07/31/2025$0.01$0.01$0.01$0.0112,700 shs$9.32 million07/30/2025$0.01$0.01-7.07%$0.01$0.01114,478 shs$9.32 million07/29/2025$0.01$0.01$0.01$0.0121,000 shs$10.03 million07/28/2025$0.01$0.01$0.01$0.01102,810 shs$10.03 million07/25/2025$0.01$0.01-1.98%$0.01$0.0146,694 shs$10.03 million07/24/2025$0.01$0.01$0.01$0.0135,000 shs$10.23 million07/23/2025$0.01$0.01+4.12%$0.01$0.0110,000 shs$10.23 million07/22/2025$0.01$0.01$0.01$0.0113,000 shs$9.82 million07/21/2025$0.01$0.01-4.90%$0.01$0.0120,100 shs$9.82 million Get the Latest News and Ratings for CUBT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.01$0.01-20.93%$0.01$0.01319,600 shs$10.33 million07/17/2025$0.01$0.01+20.56%$0.01$0.0112,000 shs$13.07 million07/16/2025$0.01$0.01+1.90%$0.01$0.01176,781 shs$10.84 million07/15/2025$0.01$0.01+19.32%$0.01$0.01177,000 shs$10.18 million07/14/2025$0.01$0.01+2.33%$0.01$0.01346,985 shs$8.53 million07/11/2025$0.01$0.01+1.18%$0.01$0.011.22 million shs$8.71 million07/10/2025$0.01$0.01-5.56%$0.01$0.0132,100 shs$8.61 million07/09/2025$0.01$0.01-10.00%$0.01$0.01542,500 shs$9.12 million07/08/2025$0.01$0.01$0.01$0.0182,150 shs$10.13 million07/07/2025$0.01$0.01+5.26%$0.01$0.0113,850 shs$10.13 million07/04/2025$0.01$0.01$0.01$0.011.04 million shs$9.62 million07/03/2025$0.01$0.01-14.41%$0.01$0.011.04 million shs$9.62 million07/02/2025$0.01$0.01-6.72%$0.01$0.0121,933 shs$11.24 million07/01/2025$0.01$0.01+3.48%$0.01$0.0112,000 shs$12.05 million Related Companies Precision BioSciences Stock Chart Jasper Therapeutics Stock Chart ZIVO Bioscience Stock Chart Century Therapeutics Stock Chart Exicure Stock Chart Gain Therapeutics Stock Chart RenovoRx Stock Chart Clearside Biomedical Stock Chart Grace Therapeutics Stock Chart Prelude Therapeutics Stock Chart Receive CUBT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CUBT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curative Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Curative Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
